Development and validity assessment of ELISA test with recombinant chimeric protein of SARS-CoV-2
Description
Serological tests developed for COVID-19 diagnostic are based on antibodies specific for SARS-CoV-2 antigens. Most of the antigens consist of a fragment or a whole amino acid sequence of the nucleocapsid or spike proteins. We evaluated a chimeric
